BioSpace News Archive

Sensient Technologies Corporation (NYSE: SXT) will hold its conference call to discuss 2018 first quarter results at 10:00 a.m. CDT on Wednesday, April 25, 2018.

Elekta (EKTA-B.ST) today announced that it is making a strategic investment in PalabraApps, LLC to advance the development of Elekta’s clinical workflow productivity and mobility tools.

German-based Sveru Sport is bringing its Amino4u capsules and homogenous powder supplements that are vegan-friendly and contain all eight essential amino acids, to Amazon.com.

Poster Presentation at EASL 2018 Builds on Previous Data Confirming HepaStem’s Therapeutic Potential Across Different Stages of the Disease

GB Sciences, Inc. announced that it has appointed John B. Davis as Executive Vice President, General Counsel - effective immediately.

InDex Pharmaceuticals Holding AB announced the agenda for its Capital Markets Day that will take place in Stockholm on Wednesday April 25, 2018, for investors, analysts and media.

West Pharmaceutical Services, Inc. announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

The Leapfrog Group released its 2018 report on bar code medication administration (BCMA).

Innovus Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has cleared the Company’s GlucoGorx™ Glucose Monitoring Test Kit that includes a glucose meter, test strips and lancet device (“GlucoGorx™ Kit”) under the 510(k) filing of its manufacturing partner, ACON Laboratories, Inc. (“ACON”) Innovus Pharma will offer the GlucoGorx™ Kit.

BiondVax Pharmaceuticals Ltd. reported today it will present at the Universal Influenza Vaccines 2018 Conference.